This significant transaction, entirely settled in Anthropic shares, has been publicly disclosed. Dimension, a venture capital fund specializing in the health sector, previously held half of Coefficient’s capital. The fund informed its investors of this transaction via a simple letter. The team behind Coefficient Bio consists of two experienced researchers who are alumni of Prescient Design, the molecular computing unit previously associated with an undisclosed entity.
Anthropic Commits $400 Million to a 10-Scientist Team for AI-Driven Drug Discovery Acceleration
By Rupert Blackwood
Investigative journalist based in Sheffield, focusing on technology's impact on society. Rupert specializes in cybercrime's effect on communities, from online fraud targeting elderly residents to cryptocurrency scams. His reporting examines social media manipulation, digital surveillance, and how criminal networks operate in cyberspace. With expertise in computer systems, he connects technical complexity with real-world consequences for ordinary people